Stocks and InvestingStocks and Investing
Mon, April 18, 2022
Sun, April 17, 2022
Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022

Matthew Harrison Maintained (BNTX) at Hold with Decreased Target to $197 on, Apr 12th, 2022


Published on 2024-10-27 20:25:14 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $217 to $197 on, Apr 12th, 2022.

Matthew has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $200 on, Friday, April 1st, 2022
  • Simon Baker of "Redburn Partners" Upgraded from Strong Sell to Hold on, Tuesday, February 1st, 2022


This is the rating of the analyst that currently disagrees with Matthew


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022